Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression, Postpartum | 4 | 2022 | 52 | 1.710 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2022 | 146 | 1.160 |
Why?
|
| Placenta Accreta | 1 | 2023 | 173 | 0.650 |
Why?
|
| Mass Screening | 4 | 2022 | 821 | 0.640 |
Why?
|
| Mood Disorders | 1 | 2019 | 129 | 0.560 |
Why?
|
| Mental Disorders | 3 | 2023 | 906 | 0.540 |
Why?
|
| Postpartum Period | 4 | 2024 | 245 | 0.520 |
Why?
|
| Parturition | 2 | 2024 | 65 | 0.380 |
Why?
|
| Peripartum Period | 2 | 2022 | 28 | 0.360 |
Why?
|
| Pregnancy | 8 | 2024 | 7459 | 0.360 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2022 | 829 | 0.300 |
Why?
|
| Docosahexaenoic Acids | 2 | 2004 | 67 | 0.240 |
Why?
|
| Texas | 3 | 2021 | 3663 | 0.200 |
Why?
|
| Fish Oils | 1 | 2004 | 82 | 0.200 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2004 | 80 | 0.190 |
Why?
|
| House Calls | 1 | 2021 | 35 | 0.170 |
Why?
|
| Postnatal Care | 1 | 2021 | 54 | 0.170 |
Why?
|
| Depressive Disorder | 2 | 2003 | 460 | 0.170 |
Why?
|
| Valproic Acid | 3 | 1998 | 140 | 0.170 |
Why?
|
| Female | 13 | 2024 | 70545 | 0.150 |
Why?
|
| Mental Health | 1 | 2023 | 378 | 0.150 |
Why?
|
| Referral and Consultation | 2 | 2022 | 565 | 0.150 |
Why?
|
| Placenta | 1 | 2023 | 500 | 0.140 |
Why?
|
| Mothers | 1 | 2021 | 385 | 0.140 |
Why?
|
| Women's Health | 1 | 1999 | 134 | 0.140 |
Why?
|
| Obstetrics | 1 | 2019 | 235 | 0.130 |
Why?
|
| Depression | 2 | 2022 | 1315 | 0.120 |
Why?
|
| Health Promotion | 1 | 1999 | 421 | 0.110 |
Why?
|
| Schizophrenia | 2 | 1995 | 324 | 0.110 |
Why?
|
| Humans | 14 | 2024 | 130534 | 0.110 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2024 | 896 | 0.110 |
Why?
|
| Neurocognitive Disorders | 1 | 1995 | 74 | 0.100 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1995 | 92 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 4058 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2019 | 715 | 0.100 |
Why?
|
| Child | 3 | 2022 | 26263 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 1995 | 363 | 0.090 |
Why?
|
| Paroxetine | 1 | 2011 | 24 | 0.090 |
Why?
|
| Fluoxetine | 1 | 2011 | 47 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 2596 | 0.090 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2011 | 84 | 0.090 |
Why?
|
| Pediatrics | 1 | 2019 | 1248 | 0.080 |
Why?
|
| Adult | 5 | 2019 | 31114 | 0.070 |
Why?
|
| Middle Aged | 5 | 2019 | 28408 | 0.070 |
Why?
|
| United States | 1 | 2021 | 12002 | 0.060 |
Why?
|
| Adolescent | 2 | 2019 | 20889 | 0.050 |
Why?
|
| Breast Self-Examination | 2 | 2005 | 2 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2004 | 67 | 0.050 |
Why?
|
| Mammography | 2 | 2005 | 121 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2004 | 82 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2004 | 179 | 0.050 |
Why?
|
| Placebos | 1 | 2003 | 223 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2004 | 216 | 0.050 |
Why?
|
| Poverty | 1 | 2005 | 462 | 0.040 |
Why?
|
| Dementia | 2 | 1998 | 435 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2004 | 344 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2022 | 250 | 0.040 |
Why?
|
| Sampling Studies | 1 | 1999 | 76 | 0.040 |
Why?
|
| Hospitals, General | 1 | 1999 | 25 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2004 | 1440 | 0.040 |
Why?
|
| Drug Tolerance | 2 | 1998 | 39 | 0.040 |
Why?
|
| Logistic Models | 2 | 2005 | 1796 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1613 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1999 | 72 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 616 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2004 | 12846 | 0.040 |
Why?
|
| GABA Agents | 1 | 1998 | 20 | 0.030 |
Why?
|
| Psychomotor Agitation | 1 | 1998 | 57 | 0.030 |
Why?
|
| Population Surveillance | 1 | 1999 | 394 | 0.030 |
Why?
|
| Psychiatry | 1 | 1999 | 272 | 0.030 |
Why?
|
| Parents | 1 | 2024 | 1126 | 0.030 |
Why?
|
| Male | 6 | 2024 | 64613 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 1995 | 43 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 1995 | 81 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 1995 | 110 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 1995 | 146 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1999 | 914 | 0.020 |
Why?
|
| Age Factors | 1 | 1999 | 2822 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 1995 | 346 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1605 | 0.020 |
Why?
|
| Aged | 4 | 2005 | 20885 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1995 | 858 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 1879 | 0.020 |
Why?
|
| Hospitalization | 1 | 1995 | 1942 | 0.020 |
Why?
|
| Digital Rectal Examination | 1 | 2005 | 5 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17634 | 0.010 |
Why?
|
| Occult Blood | 1 | 2005 | 31 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2005 | 211 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2005 | 246 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 461 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 6771 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 1589 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 511 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3685 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1998 | 953 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1998 | 375 | 0.010 |
Why?
|